Details for 2023172275
Up to date per 01.04.2026
Actions
Details for 2023172275
Granted/Registered
European Patent
30.08.2023 A
10.07.2024 B1
26.02.2015
JP
2015037462
A61K 9/20 20060101AFI20230726BHEP
Owner
Takeda Pharmaceutical Company Limited1-1, Doshomachi 4-chome Chuo-ku Osaka-shi, Osaka 541-0045JP
Representative
No representatives present
Inventor
YAMANE Ikuro Osaka-shi, 532-0024JP
NOMURA Yukihiro Osaka-shi, 532-0024JP
NISHIMOTO Yutaka Osaka-shi, 532-0024JP
HOSHINA Wataru Osaka-shi, 532-0024JP
Information about Fees